香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產 生或因依賴該等內容而引致的任何損失承擔任何責任。 （於開曼群島註冊成立的有限公司） （股份代號：3600） 授出購股權 現代牙科集團有限公司（「本公司」，連同其附屬公司為「本集團」）根據香港聯合交易 所有限公司（「聯交所」）證券上市規則（「上市規則」）第17.06A、17.06B及17.06C條 刊發本公告。 考慮到： (i) 向承授人授出購股權為認可其過往個別表 現及貢獻，其在本集團內的角色，以及對 本集團的未來潛在貢獻； – 2 – 本公司董事（「董事」）會（「董事會」）宣佈，於2025年11月28日（「授出日期」），本公 司根據本公司於2015年12月15日採納之購股權計劃（「購股權計劃」），向屬董事及 本集團僱員之若干合資格參與者（「承授人」）授出購股權（「購股權」），以認購本公司 股本中每股面值為0.01美元之合共23,250,000股普通股（「股份」），有待該等承授人 接納後作實。 授出之購股權詳情如下： 授出日期 ： 2025年11月28 ...

Core Viewpoint - The company Modern Dental (03600) reported record high revenues for the nine months ending September 30, 2025, driven by the ongoing digitalization trend in the dental industry, despite challenges in the macroeconomic environment and weak demand for dental procedures [1] Group 1: Financial Performance - Total revenue for the nine months ending September 30, 2025, reached approximately HKD 2.752 billion, an increase of about 9.2% compared to HKD 2.522 billion for the same period in 2024 [1] - Total sales volume increased by approximately 29.5% to about 2.115 million units for the nine months ending September 30, 2025, compared to approximately 1.633 million units for the same period in 2024 [3] - The average selling price of denture products in the market was HKD 1,227 per unit, a decrease of about 14.9% due to the acquisition of Hexa Ceram [4] Group 2: Market Dynamics - The digitalization trend in the dental industry is driving consolidation, allowing the company to expand its market share and improve competitiveness [1] - The company aims to shift focus from low-margin markets in mainland China to serving mid-to-high value customers to ensure long-term sustainable profitability [2] - The sales growth in Australia reflects strong growth in new digital products driven by the digitalization trend in the dental industry [3] Group 3: Operational Developments - The company’s international production facilities in Thailand, Vietnam, and mainland China are being utilized to navigate the unprecedented international trade environment [1] - The acquisition of Hexa Ceram contributed approximately 45,600 units to sales, enhancing the company's sales and distribution network in Thailand [3] - The number of digital solutions cases produced in mainland China, Thailand, and Vietnam increased to approximately 698,000, a 24.4% increase compared to 561,000 in the same period last year [4]

Core Viewpoint - The company Modern Dental (03600) reported record-high revenue for the nine months ending September 30, 2025, driven by the ongoing digitalization trend in the dental industry and improved operational efficiency, despite a challenging macroeconomic environment and weak demand for dental procedures [1] Group 1: Financial Performance - Total revenue for the nine months ending September 30, 2025, reached approximately HKD 2.752 billion, an increase of about 9.2% compared to approximately HKD 2.522 billion for the same period in 2024 [1] - Total sales volume increased by approximately 29.5% to about 2.115 million units, compared to approximately 1.633 million units for the same period in 2024 [3] - The average selling price of dental products in the market was HKD 1,227 per unit, a decrease of approximately 14.9% due to the acquisition of Hexa Ceram [4] Group 2: Market Dynamics - The company is facing challenges in the Chinese market due to volume-based procurement policies and intense long-term price competition, leading to a shift in focus towards serving mid-to-high value customers for sustainable profitability [2] - The digitalization trend in the dental industry is driving strong growth in new digital products, particularly in the Australian market [3] - The company’s international production facilities in Thailand, Vietnam, and mainland China are being utilized to navigate the unprecedented international trade environment [1] Group 3: Product and Service Development - The company has seen an increase in the number of digital solutions produced, with approximately 698,000 cases produced in mainland China, Thailand, and Vietnam, representing a 24.4% increase from approximately 561,000 cases in the same period last year [4] - The sales from the acquisition of Hexa Ceram contributed approximately 456,000 units, with the company focusing on expanding its product supply, distribution, and sales network in Thailand [3]

（於開曼群島註冊成立的有限公司） （股份代號：3600） 自願性披露 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 2025 年第三季度更新 董事會欣然就本集團截至2025年9月30日止九個月之未經審核選定營運數據作出自 願性披露及更新。 本集團的更新 截至2025年9月30日止九個月，在牙科行業數碼化趨勢持續的支持下，本集團的多 維度策略及持續提升的營運效率及生產力，使其於本期間的收益創下紀錄新高。宏 觀經濟環境充滿挑戰，牙科手術的需求普遍疲弱，且貿易戰存在不確定性，然而仍 然創下紀錄。本集團利用位於泰國、越南及中國內地的國際生產設施，積極應對前 所未有的國際貿易環境。 全球數碼化趨勢持續推動義齒行業的整合，使本集團進一步擴大其市場份額。我們 持續的數碼轉型措施提升客戶及病人體驗的同時，進一步使本集團在競爭對手中脫 穎而出，表現優於同業。 本集團的相關基礎持續穩固，並將全力以赴以進一步把握未來機遇。 – 1 – 全球收益 截至2025年9月30日 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03600 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | USD | | 0.01 | USD | | 30,000,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 3,000,000,000 | USD | | 0.01 | USD | ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 FF301 致：香港交易及結算所有限公司 公司名稱: 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年10月2日 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03600 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 934,850,000 | | 0 | | 934,850,000 | | 增加 / 減少 (-) | | | | | | | | | 本月底結存 | | | 934,850,000 | | 0 | | 934,850,000 | 第 2 頁 共 10 頁 v 1.1.1 III.已發行股份及/或庫存股份變動詳情 I. 法定/註冊股本 ...

(Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） (Stock Code 股份代號: 3600) NOTIFICATION LETTER 通知信函 Dear Non-Registered Holder (Note 1) Modern Dental Group Limited (the "Company") – Notice of publication of 2025 Interim Report ("Current Corporate Communication (Note 2) ") on the Company's website , 18 September 2025 The English and Chinese versions of the Company's Current Corporate Communications are available on the Company's website at www.moderndentalgp.com the website of The S ...

(Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） (Stock Code 股份代號: 3600) NOTIFICATION LETTER 通知信函 18 September 2025 Dear Registered Shareholder, Modern Dental Group Limited (the "Company") – Notice of publication of 2025 Interim Report ("Current Corporate Communication") on the Company's website The English and Chinese versions of the Company's Current Corporate Communications are now available on the Company's website at www.moderndentalgp.com and the website of The Stock Exchan ...

Financial Performance - For the six months ending June 30, 2025, the company's revenue was approximately HKD 1,834,814,000, an increase of about HKD 132,983,000 or 7.8% compared to HKD 1,701,831,000 for the same period in 2024[12] - The gross profit margin for the same period was approximately 54.8%, up from 53.7% in the previous year, with gross profit increasing by about HKD 91,485,000 or 10.0% to HKD 1,005,476,000[12] - EBITDA for the six months ending June 30, 2025, was approximately HKD 456,711,000, representing an increase of about HKD 81,140,000 or 21.6% compared to HKD 375,571,000 in 2024[12] - Net profit for the same period was approximately HKD 288,650,000, an increase of about HKD 74,295,000 or 34.7% from HKD 214,355,000 in 2024[12] - The company declared an interim dividend of HKD 0.107 per share, compared to HKD 0.08 per share in the previous year, reflecting a strong performance[12] Market Performance - Revenue from the European market was HKD 920,255,000, a 10.9% increase from HKD 822,914,000 in 2024, while North American revenue decreased by 5.1% to HKD 365,680,000[14] - The Greater China market revenue was HKD 293,176,000, reflecting a decrease of approximately 9.8% compared to the previous period[36] - Revenue from the Australian market was approximately HKD 137,858,000, an increase of about HKD 9,956,000 compared to the previous six months, maintaining a share of about 7.5% of total revenue[42] Product Revenue Breakdown - Fixed dental equipment revenue reached approximately HKD 1,098,288,000, an increase of about HKD 52,901,000 compared to the previous period, accounting for approximately 63.6% of total customized product revenue[22] - Removable dental equipment revenue was approximately HKD 447,394,000, an increase of about HKD 53,848,000, representing approximately 25.9% of total customized product revenue[23] - Other customized equipment revenue amounted to approximately HKD 181,639,000, an increase of about HKD 38,017,000, making up approximately 10.5% of total customized product revenue[24] Acquisitions and Investments - The company completed the acquisition of Hexa Ceram, Thailand's largest dental laboratory, in January 2025, contributing approximately HKD 88.7 million to revenue for the six months ending June 30, 2025[15] - The company has made significant acquisitions, including the recent acquisition of Hexa Ceram, enhancing its distribution and sales network in Southeast Asia[45] - The acquisition of Hexa Ceram contributed to revenue growth, although it was offset by intense price competition in Greater China and weak demand in North America due to tariff pressures[47] Operational Efficiency - The company’s core business profit margin improved to 16.1%, up from 13.5% in the previous year, indicating enhanced operational efficiency[13] - Operating expenses for sales and distribution increased by approximately 3.1% to HKD 238,044,000, accounting for about 13.0% of total revenue, down from 13.6% in 2024[50] - Administrative expenses rose by approximately 10.2% to HKD 417,636,000, representing about 22.8% of total revenue, compared to 22.3% in 2024[51] Cash Flow and Financial Position - For the six months ended June 30, 2025, the net cash flow from operating activities was approximately HKD 289,742,000, an increase of 37% compared to HKD 210,840,000 for the same period in 2024[63] - The net cash outflow from investing activities for the six months ended June 30, 2025, was approximately HKD 246,137,000, significantly higher than HKD 93,477,000 for the same period in 2024, primarily due to acquisitions[64] - The net cash outflow from financing activities for the six months ended June 30, 2025, was approximately HKD 326,777,000, compared to HKD 119,413,000 for the same period in 2024, driven by debt repayments and dividend payments[65] Employee and Shareholder Information - The company has a total of 8,594 full-time employees as of June 30, 2025, an increase from 7,106 employees as of December 31, 2024[96] - Employee costs for the six months ended June 30, 2025, amounted to approximately HKD 824,628,000, compared to HKD 786,274,000 for the same period in 2024[96] - The board declared an interim dividend of HKD 0.107 per ordinary share for the six months ended June 30, 2025, up from HKD 0.080 for the same period in 2024[93] Corporate Governance and Compliance - The company has complied with the corporate governance code as per the Stock Exchange Listing Rules during the six months ending June 30, 2025[117] - The board believes that having the same individual serve as both Chairman and CEO is beneficial for the company's strategic direction and decision-making efficiency[118] Risks and Challenges - The company faces various market risks, including global economic fluctuations and geopolitical risks, which may impact financial performance[86] - The company has not entered into any interest rate agreements or derivative transactions to hedge against interest rate fluctuations[89] Share Repurchase and Capital Management - The company repurchased 5,427,000 shares at a total cost of approximately HKD 22,440,000, with an average price per share ranging from HKD 3.73 to HKD 4.28[112] - The company aims to enhance shareholder value by increasing net asset value per share and earnings per share through share repurchases[113]

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年9月3日 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03600 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | USD | | 0.01 USD | | 30,000,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結存 | | | 3,000,000,000 | USD | | 0.01 USD | | 30,000,000 | 本月底法定/註冊股本總額： USD ...